Connecting health. Bringing silent data back into decision-making.
With “Connecting Health” as its mission, the company draws on its founding team’s deep expertise in the internet and artificial intelligence and more than a decade of focus on digital and intelligent transformation in the broader healthcare industry. With StarPlex, its pharmaceutical AI agent platform, at the core, it helps the broader healthcare industry turn “silent data assets” into “data productivity.”
Your AI-Powered Data Intelligence Partner
Weiming Penguin uses AI-native technology to rebuild industry databases for the broader healthcare industry, providing end-to-end big data products and solutions spanning data integration, governance, insights, and decision support for the industry.
Building a closed-loop business intelligence process of “data — analysis — decision-making — execution” to help the broader healthcare industry turn “silent data assets” into “data productivity.”
From Our Founding to Today
Over ten years, we have grown from a technology team into an AI-powered data intelligence partner.
Weiming Penguin incorporated
Raised tens of millions in angel funding led by Matrix Partners China
Raised tens of millions in Series A funding led by Chengwei Capital
Raised tens of millions in Series B funding led by Redstone Capital
Acquired Shandong Youdu
Recognized as a National Technology-Based Small and Medium-Sized Enterprise
Repeatedly recognized as a Technology-Based Small and Medium-Sized Enterprise
Provided pro bono support for the “Wuhan Emergency Medical and Epidemic Prevention Supplies Procurement System” during the pandemic
Continued to deepen its expertise in data governance for the pharmaceutical and broader healthcare industries
Launched StarPlex, its pharmaceutical AI agent platform, fully embracing the AI-native era